the discovery and development of liraglutide and semaglutide Reflections on the discovery GLP-1

The effect of this hormone is multi-faceted, but used as a tool for weight toss, its main mechanisms of action are: Sending a signal to the brain that satiety has been reached, which then reduces the hunger signal and can heip lead to overall reduced food intake

The first GLP-1 drug, Exenatide (brand name Byetta), was approved by the Food and Drug Administration in 2005 to treat type 2 diabetes

Understanding these differences is essential when you are thinking about switching from Tirzepatide to Retatrutide

Additionally, semaglutide lowers blood pressure and reduces inflammationtwo critical factors that slow kidney disease progression